These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7887639)

  • 21. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of a new antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), administered orally: an HCFU clinical study group report.
    Koyama Y; Koyama Y
    Cancer Treat Rep; 1980; 64(8-9):861-7. PubMed ID: 7448823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer.
    Sugimachi K; Maehara Y
    Surg Today; 2000; 30(12):1067-72. PubMed ID: 11193737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy.
    Fujikawa A; Tsuchiya K; Katase S; Kurosaki Y; Hachiya J
    Eur Radiol; 2001; 11(12):2602-6. PubMed ID: 11734966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophosphamide, adriamycin, 5-fluorouracil and high-dose toremifene for patients with advanced/recurrent breast cancer. The Japan Toremifene Cooperative Study Group.
    Tominaga T; Nomura Y; Uchino J; Hirata K; Kimura M; Yoshida M; Aoyama H; Kinoshita H; Koyama H; Monden Y; Takashima S; Ogawa M
    Jpn J Clin Oncol; 1998 Apr; 28(4):250-4. PubMed ID: 9657010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of recurrent gastric cancer successfully treated with a combination of cisplatin and carmofur].
    Kuwatsuru R; Akazawa S; Yoon S; Yamamoto K; Yoshida K; Saifuku K; Abe S; Fujiki T; Kanda Y; Futatsuki K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3143-7. PubMed ID: 3674899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial.
    Yamamoto D; Iwase S; Tsubota Y; Ariyoshi K; Kawaguchi T; Miyaji T; Sueoka N; Yamamoto C; Teramoto S; Odagiri H; Kitamura K; Nagumo Y; Yamaguchi T
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1183-9. PubMed ID: 25862350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
    Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of neoadjuvant combination chemotherapy with pirarubicin, carmofur and tamoxifen citrate on outpatients with advanced and recurrence breast cancer].
    Katsumata K; Yamashita S; Hoshino S; Tani C; Yamamoto K; Kimura K
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):273-5. PubMed ID: 8311502
    [No Abstract]   [Full Text] [Related]  

  • 32. A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer.
    Osterlund P; Elomaa I; Virkkunen P; Joensuu H
    Oncology; 2001; 61(2):113-9. PubMed ID: 11528249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Late phase II study of CGS16949A, a new aromatase inhibitor--a multicentral cooperative study (Western Japan Group)].
    Wada T; Nomura Y; Oohashi Y; Abe O; Koyama H; Takashima S
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):485-93. PubMed ID: 8129389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination chemotherapy of CPM-MTX-5-FU in non-resectable and recurrent cancer patients].
    Saeki T; Jinushi K; Kim R; Toi M; Saeki K; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):827-31. PubMed ID: 2712579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A phase II study of DWA2114R, a new platinum complex for breast cancer].
    Aoyama H; Kubo K; Uchino J; Hayasaka H; Asaishi K; Izuo M; Ogawa M; Majima H; Yasutomi M; Wada T
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1033-9. PubMed ID: 1626939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
    Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer].
    Sano M; Tokuda Y; Noguchi S; Aogi K; Saeki T; Tabei T; Hatake K; Fujii H
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1091-7. PubMed ID: 16912527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A phase I study of docetaxel (TXT) and doxifluridine (5'-DFUR) combination therapy in patients with advanced and recurrent breast cancer].
    Tominaga T; Nishimura R; Aoyama H; Iwase H; Mitsuyama S; Asaga T; Kimura M;
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):965-72. PubMed ID: 11478146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of weekly taxol (TXL) for advanced recurrent breast cancer evaluated in a multi-center cooperative clinical trial].
    Nishi T; Yamanaka E; Yamasaki M; Tanaka H; Takeda C; Ikeda N; Hoashi T; Higaki J; Matsunami T; Nakano K; Kogire M; Furukawa J; Inui N; Yamauchi E; Takagaki K; Ogino N; Nomura T; Yamada S; Fujimoto M; Uenishi M; Yayoi E;
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):897-901. PubMed ID: 15222108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A phase II study of weekly paclitaxel for advanced or recurrent breast cancer].
    Wada Y; Otoshi M; Jitsuko A; Nishikawa H; Takahara S; Tsubono M; Imai S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1041-5. PubMed ID: 17637539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.